Substituted pyrazoles as p38 kinase inhibitors

Details Substituted pyrazoles as p38 kinase inhibitors Substituted pyrazoles as p38 kinase inhibitors

2006-12-26

2006-12-26

Solola, Taofiq (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C544S126000, C546S206000, C546S257000, C546S275400

Reexamination Certificate

active

07153959

ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula IAwherein R1, R2, R3and R4are as described in the specification.

REFERENCES:
patent: 3254093 (1966-05-01), Huisgen et al.
patent: 3984431 (1976-10-01), Gueremy et al.
patent: 4000281 (1976-12-01), Beiler et al.
patent: 5051518 (1991-09-01), Murray et al.
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5486534 (1996-01-01), Lee et al.
patent: 5559137 (1996-09-01), Adams et al.
patent: 5589439 (1996-12-01), Goto et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5756529 (1998-05-01), Isakson et al.
patent: 5972972 (1999-10-01), Mihelich et al.
patent: 5998425 (1999-12-01), Adams et al.
patent: 6423713 (2002-07-01), Anantanarayan et al.
patent: 6514977 (2003-02-01), Anantanarayan et al.
patent: 6525059 (2003-02-01), Anantanarayan et al.
patent: 6617324 (2003-02-01), Naraian et al.
patent: 295 374 (1991-10-01), None
patent: 0 115 640 (1984-08-01), None
patent: 0 515 041 (1992-11-01), None
patent: 0 531 901 (1993-03-01), None
patent: 0 418 845 (1995-08-01), None
patent: 0 846 686 (1998-06-01), None
patent: 0 846 687 (1998-06-01), None
patent: 4-145081 (1992-05-01), None
patent: 5-17470 (1993-01-01), None
patent: 5-345772 (1993-12-01), None
patent: 8-183787 (1996-07-01), None
patent: WO 83/00330 (1983-02-01), None
patent: WO 92/19615 (1992-11-01), None
patent: WO 94/19350 (1994-09-01), None
patent: WO 95/06036 (1995-03-01), None
patent: WO 95/22545 (1995-08-01), None
patent: WO 95/31451 (1995-11-01), None
patent: WO 96/03385 (1996-02-01), None
patent: WO 96/21452 (1996-07-01), None
patent: WO 96/21654 (1996-07-01), None
patent: WO 96/40143 (1996-12-01), None
patent: WO 97/01551 (1997-01-01), None
patent: WO 97/23479 (1997-07-01), None
patent: WO 97/25046 (1997-07-01), None
patent: WO 97/25047 (1997-07-01), None
patent: WO 97/25048 (1997-07-01), None
patent: WO 97/32583 (1997-09-01), None
patent: WO 97/35855 (1997-10-01), None
patent: WO 97/35856 (1997-10-01), None
patent: WO 97/47618 (1997-12-01), None
patent: WO 98/07425 (1998-02-01), None
patent: WO 98/16230 (1998-04-01), None
patent: WO 98/25619 (1998-06-01), None
patent: WO 98/52937 (1998-11-01), None
patent: WO 98/52940 (1998-11-01), None
patent: WO 98/52941 (1998-11-01), None
patent: WO 98/57966 (1998-12-01), None
patent: WO 99/01130 (1999-01-01), None
patent: WO 99/01131 (1999-01-01), None
patent: WO 99/01136 (1999-01-01), None
patent: WO 99/01452 (1999-01-01), None
patent: WO 99/17776 (1999-04-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 99/61426 (1999-12-01), None
Adams, et al., “Pyrimidinylimidazole Inhibitors Of CSBP/p38 Kinase Demonstrating Decreased Inhibition Of Hepatic Cytochrome p450 Enzymes”,Bioorganic&Medicinal Chemistry Letters, vol. 8, pp. 3111-3116 (1998).
Badger, et al., “Disease-Modifying Activity Of SB 242235, A Selective Inhibitor Of p38 Mitogen-Activated Protein Kinase, In Rat Adjuvant-Induced Arthritis”,Arthritis&Rheumatism, vol. 43, No. 1, pp. 175-183 (2000).
Bauer, et al., “4-[3(5)-Pyrazolyl]Pyridinium Salts. A New Class Of Hypoglycemic Agents”,J. Med. Chem., vol. 11; pp. 981-984, (Sep. 1968).
Boehm, et al., “New Inhibitors Of p38 Kinase”,Exp Opin. Ther. Patents, vol. 10(1), pp. 25-36, (2000).
Cativiela, et al., “On the Synthesis Of 3(5)-(Carbomethoxy)-4-hetarylpyrazoles”,J. Heterocycl. Chem., vol. 25; pp. 851-855, (May-Jun. 1988).
Chemical Abstracts, 13thCollective Chemical Substance Index 1992-1996, Book 51, pp. 546-550.
De Laszlo, et al., “Pyrroles And Other Heterocycles As Inhibitors Of p38 Kinase”,Bioorg. &Med. Chem. Lett. 8, pp. 2689-2694 (1998).
Dannhardt, et al., “ω-Aminopropyl-pyrazole durch Ringtransformation von Enaminonen der Pyrrolidinreihe”,Arch. Pharm., vol. 321, pp. 17-19 (1988).
Fischer, et al., “1,3-Dipolar Additions To 7-Methylthieno [2,3-c]pyridine 1,1-dioxide”,Helv. Chim. Acta, vol. 63(6), No. 180, pp. 1719-1727 (1980).
Gallagher, et al., “Regulation Of Stress-Induced Cytokine Production By Pyridinylimidazoles; Inhibition Of CSBP Kinase”,Bioorganic&Medicinal Chemistry, vol. 5, No. 1, pp. 49-64 (1997).
Hanson, “Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis”,Exp. Opin. Ther. Patents, vol. 7, No. 7, pp. 729-733 (1997).
Henry, et al., “p38 Mitogen-Activated Protein Kinase As A Target For Drug Discovery”,Drugs of the Future, vol. 24, No. 12, pp. 1345-1354 (1999).
Huang, et al., “Synthesis and Biological Activities of 1-(substituted pyrazol-4-yl)-1,2,4-triazoles”,Chemical Abstracts, vol. 124, No. 23, Abstract No. 317062d (1996).
Huang, “The Reaction of α-Oxo-α-Triazolyketene Dithioacetal With Amines, Hydrazine and Guanidine”,Chinese Chemical Letters, vol. 5, No. 1, pp. 31-34 (1994).
Liverton, et al., “Design And Synthesis Of Potent, Selective, And Orally Bioavailable Tetrasubstituted Imidazole Inhibitors Of p38 Kinase Mitogen-Activated Protein Kinase”,J. Med. Chem., vol. 42, pp. 2180-2190 (1999).
Moerck et al., “Pyrazole Addition To Δ1-Azirines. Structure of Purported 2:1 Adducts of Δ1-Azirines With sym-Tetrazines”,J.C. Chem. Comm., No. 19, pp. 782-783. (1974).
Popova, et al., “Synthesis Of 4-(Pyrazol-4-yl)-Substituted Salts Of Pyrylium And Pyridines”,Chemical Abstracts, vol. 098, No. 1, Jan. 3, 1983, Abstract No. 4498q.
Salituro, et al., “Inhibitors of p38 MAP Kinase: Therapeutic Intervention Cytokine-Mediated Diseases”,Current Medicinal Chemistry, Issue 6, pp. 807-823 (1999).
Zhengming, et al., “Syntheses of Di-heterocyclic Compounds; Pyrazolylimidazoles And Isoxazolylimadazoles”,Heteroatom. Chem., vol. 9, No. 3, pp. 317-320 (1998).

Affiliated with

Also associated with

Rating

Substituted pyrazoles as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazoles as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazoles as p38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3720024